According to TechSci Research report, “Global Clinical Nutrition Market By Route of Administration (Oral, Intravenous), By Nutrition Type (Enteral Nutrition, Parental Nutrition), By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others), By End User (Infant & Child, Adults, Geriatrics), By Substrates (Energy, Carbohydrates, Lipids, Proteins & amino acids, Water & electrolyte, Dietary fiber, Antioxidants), By Region, Competition, Forecast & Opportunities, 2025”, the Global Clinical Nutrition market was valued at USD54.85 billion in 2019 is estimated to grow at an impressive rate of 7.36% during the forecast period. Factors contributing to the market growth include growing geriatric population and advancement in healthcare infrastructure in developing economies.

Increasing awareness pertaining to health and fitness among people, expanding global population are also contributing to the global clinical nutrition market growth. Rising personal disposable income, and surge in cases of premature birth are some of the key factors behind the growth of clinical nutrition market, globally. Increasing research and development activities for nutrition advancements expansion of key players through diverse product launches, merger & acquisition and strategic collaboration are further expected to fuel the Global Clinical Nutrition market through 2025.

Moreover, with rising prevalence of metabolic diseases, the number of patients opting for the diagnosis of metabolic disorders has also increased over the years, thereby fueling the market growth. Furthermore, various governments and international organizations are taking initiatives to improve the health rate and thus, increasing investments in healthcare sector and funding from international and national organizations is further propelling the growth of the market across the globe.

However, lack of awareness about clinical nutrients and high cost or side effects of nutritional products might hamper the growth of the market. Decrease in fertility rates and prevalence of several diseases among this population is stressing on the need of global clinical nutrition market. Additionally, stringent regulatory scenario and lack of awareness related to clinical nutrition might hamper the growth of clinical nutrition market.

Browse 199 Figures spread through 185 Pages and an in-depth TOC on " Global Clinical Nutrition Market"
https://www.techsciresearch.com/report/clinical-nutrition-market/4664.html

The global clinical nutrition market is segmented based on route of administration, nutrition type, application, end users, substrates, company and region. Based on route of administration, the market is further segmented into oral and intravenous. Among them, the oral endoscopic route of administration occupied the lion’s share in the market in 2019 as it is preferred by majority of people since, it involves lesser complexities and low cost.

Based on nutrition type, the market is segmented into enteral nutrition and parental nutrition. The enteral nutrition is further divided into oral nutrition supplements and tube feeding. The parental nutrition segment is divided into supplemental parenteral nutrition, total parenteral nutrition, all-in-one system and multiple bottle system. Globally, the enteral nutrition is anticipated to hold dominant market share until 2025 in terms of revenue owing to their ease of administration and wide availability of products like powders, capsules, soft gels, and liquids.

Nestle S.A., Danone S.A., Abbott Nutrition, Fresenius SE & Co. KGaA, Otsuka Holdings Co. Ltd., Baxter International Inc., B Braun Melsungen AG, Meiji Holding Co. Ltd., BASF SE, CONMED Corporation, Lonza Group AG, Vesco Medical LLC, Perrigo Company Plc, Pfizer Inc., Reckitt Benckiser Group Plc., and others are some of the leading players operating in global clinical nutrition market.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4664
Customers can also request for 10% free customization on this report.

“Major market players in clinical nutrition are expanding their businesses through mergers & acquisitions and strategic collaborations. The usage of nutritional products in home care sector has created more growth opportunities for companies. Over the last decade, more than 50 per cent of market share was held by infant nutrition market segment.

Hence this segment has huge growth potential for manufacturers. Therefore, the companies need to focus on launching innovative and newer clinical nutrition products to maintain a strong hold in the ever-evolving global market”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Global Clinical Nutrition Market By Route of Administration (Oral, Intravenous), By Nutrition Type (Enteral Nutrition, Parental Nutrition), By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others), By End User (Infant & Child, Adults, Geriatrics), By Substrates (Energy, Carbohydrates, Lipids, Proteins & amino acids, Water & electrolyte, Dietary fiber, Antioxidants), By Region, Competition, Forecast & Opportunities, 2025” has evaluated the future growth potential of global clinical nutrition market and provides statistics & information on market size, structure and future market growth.

The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global clinical nutrition market.

Browse Related Reports

Europe Biosimilar Insulin Glargine & Lispro Market By End User (Type 1 Diabetes and Type 2 Diabetes),By Country (Germany, United Kingdom, France, Italy, Spain, Russia, Turkey, Poland, The Netherlands, Austria & Rest of Europe), Competition, Forecast & Opportunities, 2024

https://www.techsciresearch.com/report/europe-biosimilar-insulin-glargine-and-lispro-market/4278.html

Asia Pacific Biosimilar Insulin Glargine & Lispro Market By End User (Type 1 Diabetes and Type 2 Diabetes), By Country (Japan, China, India, South Korea, Bangladesh, Pakistan), Competition, Forecast & Opportunities, 2024

https://www.techsciresearch.com/report/asia-pacific-biosimilar-insulin-glargine-and-lispro-market/4282.html

About TechSci Research

TechSci Research is a leading global market research firm publishing premium market research reports. Serving 700 global clients with more than 600 premium market research studies, TechSci Research is serving clients across 11 different industrial verticals. TechSci Research specializes in research-based consulting assignments in high growth and emerging markets, leading technologies and niche applications. Our workforce of more than 100 fulltime Analysts and Consultants employing innovative research solutions and tracking global and country specific high growth markets helps TechSci clients to lead rather than follow market trends.

Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]